foscarnet - Generic mfg.
Cytovene (ganciclovir) - Roche
Prevymis (letermovir) - Merck (MSD)
Livtencity (maribavir) - Takeda, GSK
CMV Viremia and Colitis in Simultaneous Pancreas-Kidney Transplantation. (PubMed, Am J Case Rep) - May 16, 2025 - "CONCLUSIONS In transplant patients, cytomegalovirus (CMV) infection, particularly when complicated by antiviral resistance, presents significant therapeutic challenges. A strategic approach, including the switch from ganciclovir to maribavir, foscarnet, and finally to letermovir, was critical in successfully managing the infection and preventing severe complications." 
Journal • Cytomegalovirus Infection • Gastroenterology • Gastrointestinal Disorder • Immunology • Infectious Disease • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/40375543
 
Aayushi J Rajani; Devisha Gandhi; Juhi V Amin; Justin Oring; Mipasha Patel; Shifa Karatela; Simardeep Singh
 
May 16, 2025
 
Prev Next